A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation

被引:61
|
作者
Chan, Gary C. K. [1 ]
Stjepanovic, Daniel [1 ]
Lim, Carmen [1 ]
Sun, Tianze [1 ]
Anandan, Aathavan Shanmuga [1 ]
Connor, Jason P. [1 ,2 ]
Gartner, Coral [3 ]
Hall, Wayne D. [1 ]
Leung, Janni [1 ]
机构
[1] Univ Queensland, Ctr Youth Subst Abuse Res, 17 Upland Rd, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Discipline Psychiat, St Lucia, Qld, Australia
[3] Univ Queensland, Sch Publ Hlth, St Lucia, Qld, Australia
基金
英国医学研究理事会;
关键词
E-cigarette; Vaping; Smoking; Quitting; Smoking cessation; Tobacco; CARBON-MONOXIDE; NICOTINE PATCH; VARENICLINE; EFFICACY; SMOKERS;
D O I
10.1016/j.addbeh.2021.106912
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Aim: E-cigarettes, or nicotine vaping products, are potential smoking cessation aids that provide both nicotine and behavioural substitution for combustible cigarette smoking. This review aims to compare the effectiveness of nicotine e-cigarettes for smoking cessation with licensed nicotine replacement therapies (NRT) and nicotine-free based control conditions by using network meta-analysis (NMA). Methods: We searched PubMed, Web of Science and PsycINFO for randomised controlled trials (RCTs) that allocated individuals to use nicotine e-cigarettes, compared to those that used licensed NRT (e.g., nicotine patches, nicotine gums, etc), or a nicotine-free control condition such as receiving placebo (nicotine-free) ecigarettes or usual care. We only included studies of healthy individuals who smoked. Furthermore, we identified the latest Cochrane review on NRT and searched NRT trials that were published in similar periods as the ecigarette trials we identified. NMA was conducted to compare the effect of e-cigarettes on cessation relative to NRT and control condition. Cochrane risk-of-bias tool for randomized trials Version 2 was used to access study bias. Results: For the e-cigarette trials, our initial search identified 4,717 studies and we included 7 trials for NMA after removal of duplicates, record screening and assessment of eligibility (Total N = 5,674). For NRT trials, our initial search identified 1,014 studies and we included 9 trials that satisfied our inclusion criteria (Total N = 6,080). Results from NMA indicated that participants assigned to use nicotine e-cigarettes were more likely to remain abstinent from smoking than those in the control condition (pooled Risk Ratio (RR) = 2.08, 97.5% CI = [1.39, 3.15]) and those who were assigned to use NRT (pooled RR = 1.49, 97.5% CI = [1.04, 2.14]. There was a moderate heterogeneity between studies (I2 = 42%). Most of the e-cigarette trials has moderate or high risk of bias. Conclusion: Smokers assigned to use nicotine e-cigarettes were more likely to remain abstinent from smoking than those assigned to use licensed NRT, and both were more effective than usual care or placebo conditions. More high quality studies are required to ascertain the effect of e-cigarette on smoking cessation due to risk of bias in the included studies.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Examining e-cigarettes as a smoking cessation treatment: A critical umbrella review analysis
    O'Leary, Renee
    La Rosa, Giusy Rita Maria
    Polosa, Riccardo
    DRUG AND ALCOHOL DEPENDENCE, 2025, 266
  • [32] Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis
    Guo, Kangle
    Zhou, Liying
    Shang, Xue
    Yang, Chaoqun
    Fenfen, E.
    Wang, Yan
    Xu, Meng
    Wu, Yanan
    Li, Yanfei
    Li, Meixuan
    Yang, Kehu
    Li, Xiuxia
    DRUG AND ALCOHOL DEPENDENCE, 2022, 241
  • [33] Effect of exercise type on smoking cessation: A meta-analysis of randomized controlled trials
    Klinsophon T.
    Thaveeratitham P.
    Sitthipornvorakul E.
    Janwantanakul P.
    BMC Research Notes, 10 (1)
  • [34] Effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers: Meta-analysis of randomized controlled trials
    Kim, Yeol
    Myung, Seung-Kwon
    Jeon, Young-Jee
    Lee, Eun-Hyun
    Park, Chang-Hae
    Seo, Hong Gwan
    Huh, Bong Yul
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (03) : 219 - 226
  • [35] Effects of different combined behavioral and pharmacological interventions on smoking cessation: a network meta-analysis of 103 randomized controlled trials
    Zhou, Liying
    Guo, Kangle
    Deng, Xinxin
    Shang, Xue
    E, Fenfen
    Xu, Meng
    Wu, Yanan
    Wang, Yongsheng
    Liang, Shanshan
    Yang, Kehu
    Li, Xiuxia
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2023,
  • [36] The effects of pharmacological interventions on smoking cessation in people with alcohol dependence: A systematic review and meta-analysis of nine randomized controlled trials
    Guo, Kangle
    Li, Jingwen
    Li, Jieyun
    Chen, Nan
    Li, Yanfei
    Yang, Kehu
    Li, Xiuxia
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [37] Perception of general practitioners for e-cigarettes as a smoking cessation aid: systematic review
    Selamoglu, Melis
    Erbas, Bircan
    Barton, Chris
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [38] Effects of interventions on smoking cessation: A systematic review and network meta-analysis
    Li, Ying
    Gao, Lei
    Chao, Yaqing
    Wang, Jianhua
    Qin, Tianci
    Zhou, Xiaohua
    Chen, Xiaoan
    Hou, Lingyu
    Lu, Linlin
    ADDICTION BIOLOGY, 2024, 29 (03)
  • [39] Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials
    Mottillo, Salvatore
    Filion, Kristian B.
    Belisle, Patrick
    Joseph, Lawrence
    Gervais, Andre
    O'Loughlin, Jennifer
    Paradis, Gilles
    Pihl, Robert
    Pilote, Louise
    Rinfret, Stephane
    Tremblay, Michele
    Eisenberg, Mark J.
    EUROPEAN HEART JOURNAL, 2009, 30 (06) : 718 - 730
  • [40] Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis
    Siskind, Dan J.
    Wu, Brian T.
    Wong, Tommy T.
    Firth, Joseph
    Kisely, Steve
    LANCET PSYCHIATRY, 2020, 7 (09): : 762 - 774